Status:

RECRUITING

Studying Melatonin and Recovery in Teens

Lead Sponsor:

Stanford University

Collaborating Sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions:

Juvenile; Scoliosis

Scoliosis Idiopathic

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that...

Detailed Description

The investigators will enroll a total of 45 adolescents ages 12-18 years old who are scheduled to undergo major musculoskeletal surgery and one of their caregivers who meet inclusion and exclusion cri...

Eligibility Criteria

Inclusion

  • Patients/youth:
  • Age 12-18 years
  • Participants undergoing elective major musculoskeletal surgery for eligible conditions
  • California state resident
  • Regular access to internet and smartphone
  • Can read and understand English
  • Parents/caregivers
  • Biological parent or legal guardian of youth
  • Can read and understand English

Exclusion

  • Patients/youth
  • Prescription medication for premorbid insomnia
  • Cognitive impairment or developmental delay
  • Does not agree to a 1-week washout if taking over the counter supplements or other sleep aids prior to the start of the study medication
  • High risk for sleep related breathing disorder
  • Chronic medical condition that is severe/systemic or requires regular treatment regimen
  • Psychiatric admission in prior 30 days
  • Patients that underwent major surgery in the last 3 months, or those that have not fully recovered from a prior surgery
  • BMI ≥ 99th percentile
  • Enrollment in another therapeutic study
  • Any serious underlying medical or psychiatric condition, that, in the opinion of the investigator, would contraindicate the patient\'s participation in the study

Key Trial Info

Start Date :

May 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2028

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT06093477

Start Date

May 30 2024

End Date

March 31 2028

Last Update

February 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lucile Packard Children's Hospital

Palo Alto, California, United States, 94304